Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Cardiology · ANK2-Related Cardiac Arrhythmia

Diagnosis, Testing, and Understanding Your Results

At a Glance

ANK2-related cardiac arrhythmia is diagnosed by combining symptoms, family history, ECG or rhythm-monitoring results, and genetic findings; a variant of uncertain significance is not a diagnosis and should not alone determine treatment or family testing.

Diagnosing Ankyrin-B syndrome is rarely as simple as a single blood test or heart tracing. Because the ANK2 gene affects the heart’s “scaffolding” in many ways, doctors must look at the whole picture—combining your genetic results with your personal symptoms, family history, and various heart tests [1][2].

A diagnosis typically begins with a phenotype-first approach, which means looking at how your heart is actually behaving before interpreting the DNA [3].

The Diagnostic Workup Checklist

To get a clear picture of how an ANK2 variant is affecting you, your medical team will likely use several different tools, selected according to your specific symptoms:

  • 12-Lead ECG: This is the standard test that looks at the heart’s electrical activity. Your doctor will check your QTc interval (the time it takes the heart to recharge), your resting heart rate, and your PR interval (to see how fast signals travel between chambers) [4][5].
  • Ambulatory Monitoring (Holter or Patch): Since heart rhythm issues can come and go, you might wear a portable monitor for 24 hours to 2 weeks. This can catch intermittent issues like atrial fibrillation or heart blocks that a standard ECG might miss [6][5].
  • Exercise Stress Test: This test watches how your heart’s rhythm responds to the “stress” of physical activity and the subsequent “recovery” period, which can be a key indicator for certain ANK2 patterns [7][8].
  • Cardiac Imaging (Echo or MRI): While Ankyrin-B is primarily an electrical issue, some variants are occasionally associated with structural changes like cardiomyopathy (heart muscle weakness) or noncompaction (a specific texture of the heart muscle). Imaging is used when clinically indicated to assess structure, though this is not a routine finding for all ANK2 cases [9][6].

Navigating a “VUS” Result

It is very common for genetic testing to return a Variant of Uncertain Significance (VUS). This means a change was found in your ANK2 gene, but scientists don’t yet have enough evidence to say if it is a harmless quirk of your DNA or a cause of disease [10][11].

  • A VUS is not a diagnosis. It should never be used on its own to make major medical decisions, such as getting an implanted device [11][12].
  • Treat the rhythm, not the VUS. If you have a VUS and a clear heart rhythm issue or a strong family history, the rhythm disorder is evaluated and treated on its own merits [13][14]. A VUS should not be upgraded informally to justify treatment.
  • Wait and watch. Variant classifications can change. Laboratories often re-evaluate a VUS every few years as more data becomes available from other patients worldwide. Check periodically with your genetic counselor [15][14].

The Power of Family Screening

If a pathogenic (disease-causing) variant is found, it acts as a roadmap for your family. This is called cascade screening [9].

  • Why screen asymptomatic relatives? Because Ankyrin-B syndrome has incomplete penetrance, a relative could have the gene but show no symptoms—yet they might still be at risk for a sudden rhythm event [1][16].
  • Who should be tested? Usually, testing begins with “first-degree” relatives—your parents, siblings, and children. They can have targeted genetic testing if the family variant is known to be pathogenic [3][17]. (A VUS should not be used for predictive cascade testing).
  • Clinical Evaluation: If a relative tests negative for the familial variant, they generally do not need the same level of intense cardiac follow-up [9]. However, relatives with symptoms or a concerning family history may still need a clinical ECG assessment even if genetic testing is uninformative.

Building Your Three-Generation Pedigree

One of the most valuable “tests” you can provide is a detailed family history. Your doctor will look for a “pedigree” that includes three generations, specifically asking about:

  1. Sudden, unexplained deaths (including “SIDS,” drowning, or single-vehicle accidents) [5].
  2. Anyone who received a pacemaker or defibrillator before age 50 [9].
  3. Family members with seizure-like collapses that were never fully explained by a neurologist [5].
  4. Early-onset atrial fibrillation or “enlarged heart” diagnoses [1][9].

By combining these family stories with modern testing, you and your medical team can build a personalized plan for monitoring and safety [11][5].

Common questions in this guide

What does a VUS in the ANK2 gene mean?
A VUS, or variant of uncertain significance, is an ANK2 DNA change that scientists cannot yet classify as harmful or harmless. It is not a diagnosis and should not by itself guide major decisions such as receiving an implanted heart device. The laboratory may reclassify it as more evidence becomes available.
Which heart tests are used when ANK2-related arrhythmia is suspected?
Evaluation may include a 12-lead ECG, portable monitoring for 24 hours to two weeks, and an exercise stress test. An echocardiogram or cardiac MRI may be added when symptoms or findings suggest a structural heart problem. Doctors interpret these results together with symptoms, family history, and genetic findings.
Should my relatives have genetic testing for an ANK2 variant?
If you have a confirmed pathogenic ANK2 variant, first-degree relatives—parents, siblings, and children—are often considered for targeted testing and a clinical heart evaluation. A genetic counselor can help determine who should be tested and which tests are appropriate. A VUS should not be used for predictive family testing.
What family history should I tell my doctor about?
Share any sudden unexplained deaths, drowning or single-car accidents, pacemaker or defibrillator placement before age 50, unexplained seizure-like collapses, early atrial fibrillation, or an enlarged heart in relatives. A three-generation family history can help doctors decide whether additional heart monitoring or family screening is needed.
What happens if I test negative for my family’s pathogenic ANK2 variant?
A person who tests negative for a known pathogenic family variant generally does not need the same intensive cardiac follow-up for that inherited risk. However, symptoms or a concerning family history may still warrant an ECG or other clinical evaluation, especially if the genetic result is uninformative.
Can an ANK2 gene result diagnose the condition by itself?
No. Doctors generally combine genetic results with symptoms, family history, ECGs, rhythm monitoring, and other heart tests. A genetic variant, especially a VUS, is not interpreted alone.

Get notified when new evidence is published on Cardiac arrhythmia, ankyrin-b-related.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Mechanisms underlying the role of ankyrin-B in cardiac and neurological health and disease.

    York NS, Sanchez-Arias JC, McAdam ACH, et al.

    Frontiers in cardiovascular medicine 2022; (9()):964675 doi:10.3389/fcvm.2022.964675.

    PMID: 35990955
  2. 2

    The evolving role of ankyrin-B in cardiovascular disease.

    Koenig SN, Mohler PJ

    Heart rhythm 2017; (14(12)):1884-1889 doi:10.1016/j.hrthm.2017.07.032.

    PMID: 28765088
  3. 3

    Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics.

    Arbustini E, Behr ER, Carrier L, et al.

    European heart journal 2022; (43(20)):1901-1916 doi:10.1093/eurheartj/ehab895.

    PMID: 35089333
  4. 4

    Genetic analysis of Iranian family with hereditary cardiac arrhythmias by next generation sequencing.

    Asadi M, Foo R, Samienasab MR, et al.

    Advanced biomedical research 2016; (5()):55 doi:10.4103/2277-9175.178801.

    PMID: 27110552
  5. 5

    High-degree atrioventricular block in a child with an ANK2 variant and long QT phenotype requiring leadless pacemaker implantation.

    You J

    Cardiology in the young 2026; (36(7)):1532-1535 doi:10.1017/S1047951126123464.

    PMID: 42493853
  6. 6

    Left Ventricular Non-Compaction, Atrial Fibrillation and ANK2 Mutation in a Young Athlete.

    De Masi De Luca G, Brancati E, Sciarra L, et al.

    Journal of clinical medicine research 2025; (17(1)):60-65 doi:10.14740/jocmr6126.

    PMID: 39866811
  7. 7

    Hidden Cardiac Channelopathies in Children Presenting with Syncope and Seizure-like Events.

    Aytekin Güvenir F, Özgür S

    Children (Basel, Switzerland) 2026; (13(5)) doi:10.3390/children13050669.

    PMID: 42194195
  8. 8

    Ankyrin-2 genetic variants: A case of Ankyrin-B syndrome.

    Song J, Sasmita BR, Deng G

    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2022; (27(4)):e12933 doi:10.1111/anec.12933.

    PMID: 35224819
  9. 9

    Novel Variant in the ANK2 Membrane-Binding Domain Is Associated With Ankyrin-B Syndrome and Structural Heart Disease in a First Nations Population With a High Rate of Long QT Syndrome.

    Swayne LA, Murphy NP, Asuri S, et al.

    Circulation. Cardiovascular genetics 2017; (10(1)) doi:10.1161/CIRCGENETICS.116.001537.

    PMID: 28196901
  10. 10

    Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

    Richards S, Aziz N, Bale S, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2015; (17(5)):405-24 doi:10.1038/gim.2015.30.

    PMID: 25741868
  11. 11

    [Ten questions about cardiogenetics].

    Fortuni F, Matteucci A, Angelini F, et al.

    Giornale italiano di cardiologia (2006) 2026; (27(11)):758-770 doi:10.1714/4793.48190.

    PMID: 42937170
  12. 12

    Variant reclassification and clinical implications.

    Walsh N, Cooper A, Dockery A, O'Byrne JJ

    Journal of medical genetics 2024; (61(3)):207-211 doi:10.1136/jmg-2023-109488.

    PMID: 38296635
  13. 13

    Diagnostic yield from cardiac gene testing for inherited cardiac conditions and re-evaluation of pre-ACMG variants of uncertain significance.

    Murphy J, Kirk CW, Lambert DM, et al.

    Irish journal of medical science 2024; (193(4)):1775-1785 doi:10.1007/s11845-024-03650-4.

    PMID: 38489124
  14. 14

    The frequency of gene variant reclassification and its impact on clinical management in the inherited arrhythmia clinic.

    Young WJ, Maung S, Ahmet S, et al.

    Heart rhythm 2024; (21(6)):903-910 doi:10.1016/j.hrthm.2024.01.008.

    PMID: 38218330
  15. 15

    Reclassification of Variants of Uncertain Significance in Children with Inherited Arrhythmia Syndromes is Predicted by Clinical Factors.

    Bennett JS, Bernhardt M, McBride KL, et al.

    Pediatric cardiology 2019; (40(8)):1679-1687 doi:10.1007/s00246-019-02203-2.

    PMID: 31535183
  16. 16

    Self-limited familial focal epilepsy caused by ANK2 variants: A potentially under-recognized condition.

    Lin PH, Ho CJ, Lin CH, et al.

    Epilepsia open 2025; (10(2)):635-642 doi:10.1002/epi4.70003.

    PMID: 39962910
  17. 17

    Cardiac Abnormalities in First-Degree Relatives of Unexplained Cardiac Arrest Victims: A Report From the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry.

    Steinberg C, Padfield GJ, Champagne J, et al.

    Circulation. Arrhythmia and electrophysiology 2016; (9(9)).

    PMID: 27635072

This page is for informational purposes only and does not constitute medical advice. A cardiologist, cardiac electrophysiologist, or genetic counselor should interpret your ANK2 results and guide care for your situation.